V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10002553 | 10001674 | 1.71 | null | Palliative (P) | 2014-02-07 | 2014-02-09 | CVP R | N | null | 10438206 | CVP R |
| 10002554 | 10001674 | null | 65 | Disease modification (D) | 2018-01-14 | 2018-08-28 | Enzalutamide | 2 | N | 10438206 | ENZALUTAMIDE |
| 10002555 | 10001675 | 1.48 | 63 | Curative (C) | 2015-06-25 | 2015-08-28 | CVP R | N | N | 10438243 | CVP R |
| 10002556 | 10001676 | 1.7 | null | Disease modification (D) | 2014-12-21 | 2015-01-02 | Rituximab | 02 | Y | 10438277 | RITUXIMAB |
| 10002557 | 10001677 | 1.74 | 69.5 | Palliative (P) | 2016-01-19 | 2016-02-24 | CVP R | N | N | 10438293 | CVP R |
| 10002558 | 10001678 | 1.72 | 70.8 | Adjuvant (A) | 2015-03-18 | 2015-03-24 | Cisplatin + Vinorelbine (IV) | N | N | 10438323 | CISPLATIN + VINORELBINE |
| 10002559 | 10001679 | 1.8 | 75.8 | Palliative (P) | 2016-05-15 | 2016-06-16 | Enzalutamide | 02 | N | 10438343 | ENZALUTAMIDE |
| 10002560 | 10001680 | 1.82 | 62.8 | Disease modification (D) | 2014-10-01 | 2014-10-04 | Hydroxycarbamide | 02 | N | 10438386 | HYDROXYCARBAMIDE |
| 10002561 | 10001681 | 1.73 | 54.2 | Palliative (P) | 2015-09-11 | 2015-09-12 | Gemcitabine day 1&8 | null | N | 10438409 | GEMCITABINE |
| 10002562 | 10001682 | 1.77 | 0 | Palliative (P) | 2017-01-06 | 2017-01-10 | Trial Unspecified | Y | N | 10438474 | TRIAL |
| 10002563 | 10001683 | 1.68 | 0 | Palliative (P) | 2016-08-07 | 2016-09-04 | Cisplatin + Pemetrexed | N | N | 10438513 | CISPLATIN + PEMETREXED |
| 10002564 | 10001683 | 1.68 | 101 | Disease modification (D) | 2017-03-24 | 2017-05-07 | Hydroxycarbamide | 02 | N | 10438513 | HYDROXYCARBAMIDE |
| 10002565 | 10001683 | 1.68 | null | Not known (9) | 2017-03-05 | 2017-03-08 | Trial Unspecified | N | N | 10438513 | TRIAL |
| 10002566 | 10001684 | 1.73 | 0 | Palliative (P) | 2018-06-17 | 2018-07-02 | Cisplatin + Pemetrexed | 02 | null | 10438631 | CISPLATIN + PEMETREXED |
| 10002567 | 10001685 | 1.73 | 0 | Palliative (P) | 2016-09-19 | 2016-09-20 | Enzalutamide | 2 | N | 10438722 | ENZALUTAMIDE |
| 10002568 | 10001686 | null | null | Palliative (P) | 2017-05-09 | 2017-05-16 | PEMBROLIZUMAB | 01 | N | 10438754 | PEMBROLIZUMAB |
| 10002569 | 10001686 | null | 73.4 | Palliative (P) | 2016-08-07 | 2016-08-20 | CARBOPLATIN + VINORELBINE | 2 | N | 10438754 | CARBOPLATIN + VINORELBINE |
| 10002570 | 10001687 | 1.69 | 67.9 | Palliative (P) | 2018-07-05 | 2018-07-26 | Gemcitabine weekly | null | null | 10438762 | GEMCITABINE |
| 10002571 | 10001688 | 1.69 | 76 | null | 2018-01-05 | 2018-01-29 | ECX | N | null | 10438789 | ECX |
| 10002572 | 10001689 | 1.72 | null | Palliative (P) | 2016-10-08 | 2016-10-08 | Cisplatin + Pemetrexed | N | N | 10438825 | CISPLATIN + PEMETREXED |
| 10002573 | 10001689 | 1.69 | 59.4 | Palliative (P) | 2016-07-24 | 2016-07-30 | EOX | N | N | 10438825 | EOX |
| 10002574 | 10007994 | 1.78 | 0 | Disease modification (D) | 2015-02-27 | 2015-02-27 | Hydroxycarbamide | 2 | N | 10439011 | HYDROXYCARBAMIDE |
| 10002575 | 10001690 | 1.6 | 102 | Radical (R) | 2016-01-21 | 2016-01-22 | Rituximab | 02 | N | 10439049 | RITUXIMAB |
| 10002576 | 10001691 | 1.66 | 39.1 | Palliative (P) | 2018-04-13 | 2018-04-14 | R GCVP | 02 | N | 10439051 | CVP R |
| 10002577 | 10001692 | 1.7 | 64.8 | Adjuvant (A) | 2013-08-09 | 2013-08-27 | CARBOPLATIN + VINORELBINE | 02 | N | 10439082 | CARBOPLATIN + VINORELBINE |
| 10002578 | 10001692 | 0 | 75.7 | Adjuvant (A) | 2016-06-17 | 2016-06-22 | Cisplatin + Vinorelbine (PO) | 02 | N | 10439082 | CISPLATIN + VINORELBINE |
| 10002579 | 10001692 | 1.75 | 94.2 | Palliative (P) | 2018-03-29 | 2018-04-16 | PEMBROLIZUMAB | N | N | 10439082 | PEMBROLIZUMAB |
| 10002580 | 10001693 | 1.68 | 59.6 | Palliative (P) | 2018-07-28 | 2018-08-19 | Carboplatin + Vinorelbine Oral | 2 | N | 10439242 | CARBOPLATIN + VINORELBINE |
| 10002581 | 10001694 | 1.7 | 72.9 | Palliative (P) | 2015-11-08 | 2015-11-23 | Rituximab | N | null | 10439261 | RITUXIMAB |
| 10002582 | 10001694 | 1.75 | 0 | null | 2016-09-22 | 2016-09-23 | Gemcitabine 1000mg/m2 D1 8 15 | N | null | 10439261 | GEMCITABINE |
| 10002583 | 10001694 | null | 100.6 | Palliative (P) | 2017-04-25 | 2017-04-30 | PEMBROLIZUMAB | 02 | N | 10439261 | PEMBROLIZUMAB |
| 10002584 | 10001695 | 1.55 | 121 | Palliative (P) | 2016-11-02 | 2016-11-06 | CHEMO-T TRIAL | N | null | 10439302 | TRIAL |
| 10002585 | 10001696 | 1.75 | 76 | Disease modification (D) | 2016-03-15 | 2016-06-14 | Hydroxycarbamide | 2 | null | 10439356 | HYDROXYCARBAMIDE |
| 10002586 | 10001697 | 1.7 | 97.6 | Palliative (P) | 2013-10-02 | 2013-10-02 | Gemcitabine weekly | N | N | 10439362 | GEMCITABINE |
| 10002587 | 10001698 | 1.75 | null | Disease modification (D) | 2017-07-18 | 2017-08-01 | CVP R | N | N | 10439371 | CVP R |
| 10002588 | 10001699 | 1.65 | 0 | Palliative (P) | 2017-11-16 | 2017-12-01 | Cisplatin + Pemetrexed | null | null | 10439385 | CISPLATIN + PEMETREXED |
| 10002589 | 10001700 | 1.77 | 71.4 | Not known (9) | 2015-10-23 | 2015-11-11 | Cisplatin + Vinorelbine (IV) | 02 | N | 10439401 | CISPLATIN + VINORELBINE |
| 10002590 | 10006230 | 1.63 | 0 | Curative (C) | 2016-11-14 | 2016-12-09 | Carboplatin + Vinorelbine Oral | N | Y | 10439443 | CARBOPLATIN + VINORELBINE |
| 10002593 | 10001701 | 0 | 79 | Adjuvant (A) | 2018-01-20 | 2018-02-09 | Cisplatin + Vinorelbine (IV) | 2 | N | 10439524 | CISPLATIN + VINORELBINE |
| 10002594 | 10001701 | 1.73 | 0 | Palliative (P) | 2014-03-10 | 2014-03-16 | ECX | 02 | N | 10439524 | ECX |
| 10002595 | 10001702 | 1.78 | 74.5 | Disease modification (D) | 2017-01-20 | 2017-01-23 | CVP R | 02 | N | 10439579 | CVP R |
| 10002596 | 10001703 | 1.8 | 84 | Neo-adjuvant (N) | 2016-06-15 | 2016-06-21 | EOX | 02 | N | 10439593 | EOX |
| 10002597 | 10001704 | 1.57 | 81 | Palliative (P) | 2018-01-27 | 2018-02-13 | CARBOPLATIN + VINORELBINE | 2 | N | 10439617 | CARBOPLATIN + VINORELBINE |
| 10002598 | 10001705 | 1.8 | 66 | Disease modification (D) | 2016-05-06 | 2016-05-07 | Hydroxycarbamide | N | N | 10439619 | HYDROXYCARBAMIDE |
| 10002599 | 10001706 | null | 106 | Palliative (P) | 2015-08-02 | 2015-08-15 | Enzalutamide | N | null | 10439632 | ENZALUTAMIDE |
| 10002600 | 10001706 | 1.74 | 81.5 | Palliative (P) | 2014-07-15 | 2014-07-25 | CVP R | 02 | N | 10439632 | CVP R |
| 10002601 | 10001707 | 1.56 | null | Palliative (P) | 2018-03-21 | 2018-04-10 | EOX | N | N | 10439699 | EOX |
| 10002602 | 10001708 | 1.48 | 67 | Palliative (P) | 2017-02-17 | 2017-02-21 | CVP R | 2 | N | 10439719 | CVP R |
| 10002603 | 10001709 | 1.7 | 89.6 | Not known (9) | 2018-04-09 | 2018-04-28 | EOX | N | N | 10439721 | EOX |
| 10002604 | 10001710 | 1.74 | 0 | null | 2018-03-16 | 2018-03-18 | PEMBROLIZUMAB | 2 | N | 10439731 | PEMBROLIZUMAB |